دورية أكاديمية
أعرض في EDS

Bile reflux gastropathy: Prevalence and risk factors after therapeutic biliary interventions: A retrospective cohort study.

التفاصيل البيبلوغرافية
العنوان: Bile reflux gastropathy: Prevalence and risk factors after therapeutic biliary interventions: A retrospective cohort study.
المؤلفون: Othman AAA; Department of Internal Medicine, Faculty of Medicine, Suez University, Suez, Egypt., Dwedar AAZ; Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt., ElSadek HM; Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt., AbdElAziz HR; Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Abdelrahman AAF; Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
المصدر: Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2021 Dec 06; Vol. 72, pp. 103168. Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: England NLM ID: 101616869 Publication Model: eCollection Cited Medium: Print ISSN: 2049-0801 (Print) Linking ISSN: 20490801 NLM ISO Abbreviation: Ann Med Surg (Lond) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2023- : [London] : Wolters Kluwer
Original Publication: London : Surgical Associates Ltd., 2012-
مستخلص: Background: Bile reflux gastropathy is caused by the backward flow of duodenal fluid into the stomach. A retrospective cohort study was performed to declare if the therapeutic biliary interventions cause bile reflux gastropathy, and to estimate its prevalence and risk factors, and to evaluate the gastric mucosa endoscopic and histopathologic changes.
Methods: 62 patients, with epigastric pain and/or dyspeptic symptoms, were grouped into, Group 1 : (34) patients that had undergone cholecystectomy and Group 2 : (28) patients who had undergone at least one of the following procedures for the treatment of benign pathology: endoscopic sphincterotomy and endoscopic stenting. Their ages ranged from 27 to 59 years. All participants had undergone gastroscopy for gastric aspirate analysis as well as gastric mucosa biopsy for histopathological examination.
Results: the prevalence of bile reflux gastropathy was (21.34%) after therapeutic biliary interventions with a P -value of 0.000. In both groups, diabetes, obesity, increased gastric bilirubin, and increased gastric pH were risk factors for bile reflux gastropathy (r = 0.27, 0.31, 0.68, 0.59 respectively) , while age, sex, epigastric pain, heartburn, vomiting were mot.
Conclusion: bile reflux gastropathy is common after therapeutic biliary interventions being more among obese and diabetic patients.
Competing Interests: None for all authors.
(©2021PublishedbyElsevierLtdonbehalfofIJSPublishingGroupLtd.)
References: BMC Gastroenterol. 2008 Feb 11;8:4. (PMID: 18267026)
Aliment Pharmacol Ther. 2010 Aug;32(3):334-43. (PMID: 20491749)
J Clin Gastroenterol. 2008 Nov-Dec;42(10):1103-9. (PMID: 18936645)
J Diabetes Complications. 2021 Feb;35(2):107733. (PMID: 32948398)
Physiol Meas. 1999 May;20(2):149-58. (PMID: 10390017)
Int J Surg. 2019 Dec;72:156-165. (PMID: 31704426)
J Clin Biochem Nutr. 2012 May;50(3):217-21. (PMID: 22573924)
Int J Clin Exp Pathol. 2015 Feb 01;8(2):1384-92. (PMID: 25973022)
World J Gastroenterol. 2009 Jan 21;15(3):334-8. (PMID: 19140233)
Obes Surg. 2018 Feb;28(2):559-566. (PMID: 29230622)
Aliment Pharmacol Ther. 2012 Oct;36(8):736-43. (PMID: 22928604)
Digestion. 2005;71(2):65-71. (PMID: 15775673)
Am Fam Physician. 2014 May 15;89(10):795-802. (PMID: 24866215)
Gastrointest Endosc. 2017 Jan;85(1):32-47. (PMID: 27546389)
Semin Diagn Pathol. 2005 Nov;22(4):273-83. (PMID: 16939055)
Obes Surg. 2018 Feb;28(2):389-395. (PMID: 28849330)
Rom J Morphol Embryol. 2005;46(4):269-74. (PMID: 16688361)
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1389-1392. (PMID: 29505908)
J Clin Biochem Nutr. 2010 Jan;46(1):81-6. (PMID: 20104269)
Radiat Prot Dosimetry. 2017 Dec 1;177(3):243-249. (PMID: 28419374)
Carcinogenesis. 2008 Dec;29(12):2385-93. (PMID: 18775915)
World J Surg Oncol. 2012 Nov 09;10:237. (PMID: 23137333)
فهرسة مساهمة: Keywords: Bile reflux; Bilirubin; Cholecystectomy; ERCP
تواريخ الأحداث: Date Created: 20211222 Latest Revision: 20220429
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8661444
DOI: 10.1016/j.amsu.2021.103168
PMID: 34934491
قاعدة البيانات: MEDLINE
الوصف
تدمد:2049-0801
DOI:10.1016/j.amsu.2021.103168